News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
February, 2025
February 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
2425262728  
Myeloma Paper of the Day, February 9th, suggested by Robert Orlowski
Feb 9, 2025, 13:28

Myeloma Paper of the Day, February 9th, suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Evaluation of characteristics and prognostic factors of early progressive disease in newly diagnosed myeloma (<18 months) finds higher median age, β2, LDH, stage, more ultra-high risk disease and lower hemoglobin and eGFR.”

Evaluation of Clinical Characteristics and Prognostic Factors of Early Progressive Disease (EPD) in Newly Diagnosed Multiple Myeloma Patients: Real-World Data of the Greek Myeloma Study Group

Authors: Eirini Katodritou et al.
Myeloma Paper of the Day, February 9th, suggested by Robert Orlowski
More posts featuring Robert Orlowski.
cancer Early Progressive Disease Eirini Katodritou EPD MD Anderson Cancer Center Myeloma Paper of the Day OncoDaily Oncology Robert Orlowski
Special Coverage
Blog
Feb 9, 2025, 14:23
Aruni Ghose: Systematic review on exosomal biomolecules as noninvasive biomarkers in Prostate Cancer
Blog
Feb 9, 2025, 14:15
2025 Updates in Bladder and UT Cancers for Patients and their Loved Ones - Fred Hutchinson Cancer Center
Blog
Feb 9, 2025, 14:06
Be the Change: Transform Healthcare Together - ELPA
Blog
Feb 9, 2025, 13:58
Carmen Uscatu: The change you want to see
Science
Feb 9, 2025, 13:28
Myeloma Paper of the Day, February 9th, suggested by Robert Orlowski
Blog
Feb 9, 2025, 13:23
Sana Al Sukhun: Enjoyed joining Emirates Oncology Society
Blog
Feb 9, 2025, 12:29
NIH lowered the maximum indirect cost rate research institutions can charge the government to 15%
Blog
Feb 9, 2025, 12:28
Jason Westin: The NIH will slash indirect costs on grants
Blog
Feb 9, 2025, 06:44
Sumanta K. Pal: We have extended our abstract submission deadline for SoCalGU25
Drugs
Feb 9, 2025, 05:06
Estela Rodriguez: A new option for a small subgroup of lung adenocarcinoma approved by FDA
Blog
Feb 9, 2025, 04:51
Shankar Siva: SABR vs thermal ablation
Blog
Feb 9, 2025, 04:49
Chirag Shah: Why the time is now to eliminate/rethink the PPS exemption?